3,4-dihydroxyphenylglycol has been researched along with ANS (Autonomic Nervous System) Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentho, O; Eldadah, BA; Goldstein, DS; Grossman, E; Holmes, C; Imrich, R; Pechnik, S; Sharabi, Y | 1 |
| Cannon, RO; Dendi, R; Eisenhofer, G; Esler, MD; Frank, SM; Goldstein, DS; Holmes, C; Sharabi, Y | 1 |
| Goldstein, DS; Holmes, C; Kopin, IJ; Patronas, N | 1 |
| Brentzel, S; Eisenhofer, G; Goldstein, DS; Holmes, C; Sharabi, Y | 1 |
| Freeman, R; Goldstein, DS; Holmes, C; Kaufmann, H | 1 |
| Baucom, CE; Goldstein, DS; Kopin, IJ; Polinsky, RJ; Yamamoto, T | 1 |
| Ito, T; Okumura, K | 1 |
2 trial(s) available for 3,4-dihydroxyphenylglycol and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; Coronary Circulation; Dihydroxyphenylalanine; Dopamine; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Hypotension, Orthostatic; Lower Body Negative Pressure; Male; Methoxyhydroxyphenylglycol; Myocardium; Norepinephrine; Reference Values; Sympathetic Nervous System; Syncope, Vasovagal; Syndrome; Tachycardia; Tomography, Emission-Computed; Yohimbine | 2002 |
Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Blood Pressure; Catecholamines; Chronic Disease; Diet; Droxidopa; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine | 2004 |
5 other study(ies) available for 3,4-dihydroxyphenylglycol and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension.
Topics: Adrenergic beta-Agonists; Aged; Autonomic Nervous System Diseases; Blood Pressure; Dopamine; Female; Heart; Hemodynamics; Humans; Hypotension, Orthostatic; Isoproterenol; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Statistics, Nonparametric; Sympathectomy; Sympathomimetics; Tyramine | 2009 |
Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension.
Topics: Aged; Alzheimer Disease; Autonomic Nervous System Diseases; Case-Control Studies; Catechols; Chronic Disease; Humans; Hypotension, Orthostatic; Linear Models; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Norepinephrine | 2003 |
Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension.
Topics: Adrenal Medulla; Aged; Autonomic Nervous System Diseases; Catechols; Epinephrine; Female; Heart Conduction System; Humans; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Parkinson Disease; Shy-Drager Syndrome; Supine Position; Sympathetic Nervous System | 2003 |
Plasma sulfoconjugated dopamine levels are normal in patients with autonomic failure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autonomic Nervous System Diseases; Case-Control Studies; Dihydroxyphenylalanine; Dopamine; Humans; Hypotension, Orthostatic; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Sulfates | 1996 |
[Simultaneous liquid chromatographic determination of plasma 3,4-dihydroxyphenylglycol and norepinephrine as indicators of sympathetic activity].
Topics: Adult; Autonomic Nervous System Diseases; Chromatography, High Pressure Liquid; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Posture; Sympathetic Nervous System | 1990 |